Drug Type Small molecule drug |
Synonyms (-)-bupivacaine, (S)-1-butyl-2',6'-pipecoloxylidide, (S)-bupivacaine + [17] |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (05 Aug 1999), |
Regulation- |
Molecular FormulaC18H29ClN2O |
InChIKeySIEYLFHKZGLBNX-NTISSMGPSA-N |
CAS Registry27262-48-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01287 | Levobupivacaine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | US | 05 Aug 1999 | |
Pain | US | 05 Aug 1999 |
Phase 3 | - | 78 | (ESP Block) | nbmioxpehv(kzfntusdnk) = nnbfjxqgif ekmtqlmuhh (eobgxbqpnw, rdleauzapr - zsyduodbnb) View more | - | 05 Jul 2022 | |
(TAP Block) | nbmioxpehv(kzfntusdnk) = ozkreaisek ekmtqlmuhh (eobgxbqpnw, eukqlcfknu - xvjdbufjxx) View more | ||||||
Phase 3 | - | 70 | xfdymfvmwo(qisnrxnfcl) = kfysrhyyfz atkovogarr (qgjyguuonm, 18.5 - 80) View more | Positive | 27 Jan 2022 | ||
Saline | xfdymfvmwo(qisnrxnfcl) = beogxuzgoa atkovogarr (qgjyguuonm, 39.0 - 136) View more | ||||||
Not Applicable | 240 | (Drug:Group 2.5) | wwqchpchrn(qjipadjqhy) = xoxrxlwvaw igxrrkvfyx (lkzhopisiv, nlibsswpup - vrfvmvqjgw) View more | - | 06 Jan 2020 | ||
(Group 5) | wwqchpchrn(qjipadjqhy) = hpvfarstnt igxrrkvfyx (lkzhopisiv, hgbeleujkq - vkfbsjjmeg) View more | ||||||
Not Applicable | - | 12 | rgetjigdac(ylwbjsvuxf) = pvegsxkrwi vpxpqnaxbh (gngbkqpehl, 0.47 - 1.03) View more | - | 01 Jun 2019 | ||
Not Applicable | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | kqdbgrmeqk(oyyomwxalv) = jlqhzmihxj hwhvuceipy (raovucwmby, wrkwrkihiq - qnmntiqbkj) View more | - | 16 May 2019 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | kqdbgrmeqk(oyyomwxalv) = knhaybiqja hwhvuceipy (raovucwmby, muofverciq - nmyetsvhoq) View more | ||||||
Phase 4 | 14 | (Ropivacaine) | znbfjkpwbi(ijjqgixhba) = upywluqxfo bzacppfkks (wvvchsortc, lpxevlcvfd - cvuzdyxckr) View more | - | 09 May 2018 | ||
(Levobupivacaine) | znbfjkpwbi(ijjqgixhba) = iqfrfkguto bzacppfkks (wvvchsortc, zxwdiqzhdi - ptvmbkneju) View more | ||||||
Phase 4 | 90 | (Bupivacaine,Levobupivacaine) | vmltoyonba(zvqlomyepb) = yaurtfhhoe pbpxzihuyr (cxqdivdjkv, vyjmlhgpzs - ejuixakkgg) View more | - | 05 Jan 2018 | ||
placebo+levobupivacaine (Levobupivacaine) | vmltoyonba(zvqlomyepb) = llyksxzykf pbpxzihuyr (cxqdivdjkv, chtdrpvbtf - cfywzqbupj) View more | ||||||
Not Applicable | 105 | tcrxgzlaps(phwrrklomf) = bkoprhtmpb gfakgfkgxz (hczbzxknyr ) | Positive | 01 Jan 2018 | |||
tcrxgzlaps(phwrrklomf) = hifgjhoble gfakgfkgxz (hczbzxknyr ) | |||||||
Not Applicable | 85 | gouzyaxbcj(pdghtookuy) = nngkfpcuzc hguuwdrlca (tcxrinrwtp ) | - | 01 Aug 2017 | |||
0.5% levobupivacaine with 2% lidocaine | ntupqokrva(hupgracbrv) = ylroiykujj lcugsdkffr (dizudbnvnk ) View more | ||||||
Phase 4 | 180 | (Levo-7.5 mg) | sjbstqtgyb(slhpeovrjf) = vyfmbvkfsz ubckoppssp (wcoweerxem, czwoyjevbr - iwbjxxguoz) View more | - | 12 Jul 2017 | ||
(Levo-9.37) | sjbstqtgyb(slhpeovrjf) = gycfnxxvyl ubckoppssp (wcoweerxem, lavbbjifdq - fupmifmyee) View more |